OHI Price Prediction Next Week
Technical Analysis: Based on the latest data, OHI has shown bearish signals with a -2.77% decline on February 10, closing at $36.87. The stock has fallen for 3 consecutive days and dropped in 6 out of the last 10 trading sessions, indicating increasing selling pressure.
Support and Resistance Levels:
- Key resistance levels: $37.36 (1.33% above current price)
- Key support levels: $36.84 (-0.08% below current price)
Price Trend Analysis: The stock is currently in a falling trend in the short term. Technical indicators suggest further weakness ahead, with the stock expected to decline by approximately -8.89% over the next 3 months, with a 90% probability of trading between $32.50 and $34.74.
News Impact: Recent significant developments include:
- OHI has crossed below its critical moving average
- Multiple analyst ratings have been issued:
- JMP Securities: Hold rating
- Scotiabank: Hold rating
- BMO Capital: Buy rating
Market Position:
- Current market cap: $10.34 billion
- P/E ratio: 28.38
- The stock recently paid a dividend of $0.670 with an ex-dividend date of February 10, 2025
Price Prediction for Next Week: Based on technical analysis and current market conditions:
- Expected trading range: $35.90 to $37.84
- Predicted fair opening price on February 11: $36.85
Recommendation: SELL Rationale:
- Multiple negative technical signals
- Declining trend momentum
- Breaking below critical moving averages
- Weakening market sentiment
OHI Similar Chart Price Prediction
The price of OHI is predicted to go up 1.27%, based on the high correlation periods with VRE. The similarity of these two price pattern on the periods is 94.87%.
OHI
VRE
Up: 1.27%Similarity: 94.87%
OHI Revenue Forecast
OHI EPS Forecast
OHI FAQs
What is bull’s view on OHI?
What is bear's view on OHI?
What is OHI revenue forecast for next quarter？
OHI Analyst's Forecast
Kai Klose
Berenberg
Strong Buy
2024-10-18
Price Target
$45
Upside
+8.15%
Berenberg initiated coverage of Omega Healthcare with a Buy rating and $45 price target. Healthcare real estate investment trusts in the U.S. were heavily affected by COVID-19, as capital markets took a more cautious view on the sector due to concerns about the solvency of operators, the analyst tells investors in a research note. However, with interest rates likely to take a downward trajectory, the share prices of healthcare REITs have already started to stabilize, contends the Berenberg. As a results, it expects the capital markets will view the supportive market fundamentals for Omega Healthcare Investors and Global Medical REIT more positively given the demographic development of the companies.
Juan Sanabria
BMO Capital
Hold
2024-10-07
Price Target
$44 → $45
Upside
+13.92%
Connor Siversky
Wells Fargo
Buy
2024-10-01
Price Target
$40 → $43
Upside
+6.46%
